Yearly Archives: 2006

Having diabetes should not automatically disqualify you from being considered for a heart transplant, according to a study published in Circulation: Journal of the American Heart Association.

A study published in the journal "Progress in Cardiovascular Diseases" refutes the frequently repeated claims that a comprehensive salt reduction would not produce any overall health benefits, or would even increase diseases and shorten the life-span.

Seniors who have diabetes face a very different set of health problems if they are diagnosed during middle age than if they are able to ward off the disease until their golden years, according to a new study.

People who drink coffee, including those who used to drink it but quit, are less likely to get type 2 diabetes than those who never drank it, according to a study.

Three new studies demonstrated that transoral endoscopic surgical techniques, entering the abdomen through oral cavities such as the nose and mouth, can be successful in human patients.

Subsequent announcement provides two additional lot numbers that are included in the distribution of counterfeit products, along with descriptions of how to identify them.

Researchers have deciphered the three-dimensional structure of insulin-degrading enzyme, a promising target for new drugs because it breaks down not only insulin but also the amyloid-beta protein.

A noninvasive tool that measures the skin's autofluorescence could help doctors determine whether people with diabetes are beginning to develop serious complications, according to a study.

Numerous studies show the African-Americans receive worse quality of care relative to white Americans across a broad array of medical conditions. A new study shows that such disparities in care cannot simply be attributed to low-performing health plans.

Joslin Diabetes Center, the global leader in diabetes research, care and education, has announced its partnership with Acadie-Bathurst Health Authority (ABHA) in New Brunswick, Canada.

A new study published in the international open-access medical journal PLoS Medicine, finds that older people with diabetes are much more likely to die from cardiovascular disease than their non-diabetic peers.

A new systematic review calls into the question the health benefits versus risks of pioglitazone (Actos), an oral medicine widely prescribed for diabetes throughout the United States, Canada, Europe and Asia.

Diabetic patients who use newer technologies such as insulin pumps and blood glucose monitoring devices are better able to manage their disease and adhere to treatment regimens, yet researchers have found that the newer methods are not being widely used because physicians may be reluctant to prescribe them, and even patients who are using them may not be deriving their full benefits.

A new drug billed as a magic bullet for obesity does help people lose weight, although not that much weight, and also helps lower cardiac risk factors, according to a review of studies.

Patients who have high blood sugar before undergoing surgery run an increased risk of developing blood clots, deep vein thrombosis and even pulmonary embolism after surgery.

The FTC and the FDA, working with government agencies in Mexico and Canada, have launched a drive to stop deceptive Internet advertisements and sales of products misrepresented as cures or treatments for diabetes.